Skip to main content
  • 2972 Accesses

Abstract

Obesity has reached what may be considered epidemic proportions in the United States, not only for adults but for children. Because of the medical implications and health care costs associated with obesity, as well as the negative social and psychological impacts, many individuals turn to nonprescription nutritional weight loss supplements hoping for a quick fix, and the weight loss industry has responded by offering a variety of products that generates billions of dollars each year in sales. Most nutritional weight loss supplements are purported to work by increasing energy expenditure, modulating carbohydrate or fat metabolism, increasing satiety, inducing diuresis, or blocking fat absorption. To review the literally hundreds of nutritional weight loss supplements available on the market today is well beyond the scope of this chapter. Therefore, several of the most commonly used supplements were selected for critical review, and practical recommendations are provided based on the findings of well controlled, randomized clinical trials that examined their efficacy. In most cases, the nutritional supplements reviewed either elicited no meaningful effect or resulted in changes in body weight and composition that are similar to what occurs through a restricted diet and exercise program. Although there is some evidence to suggest that herbal forms of ephedrine, such as ma huang, combined with caffeine or caffeine and aspirin (i.e., ECA stack) is effective for inducing moderate weight loss in overweight adults, because of the recent ban on ephedra manufacturers must now use ephedra-free ingredients, such as bitter orange, which do not appear to be as effective. The dietary fiber, glucomannan, also appears to hold some promise as a possible treatment for weight loss, but other related forms of dietary fiber, including guar gum and psyllium, are ineffective.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Radimer KL, Subar AF, Thompson FE. Nonvitamin, nonmineral dietary supplements: issues and findings from NHANES III. J Am Diet Assoc 2000;100:447–454.

    Article  CAS  Google Scholar 

  2. Bryant J. Fat is a $34 billion business. Atlanta Business Chronicle September 24, 2001. http://atlanta.bizjournals.co/atlanta/stories/2001/09/24/story4.html/. Accessed May 11, 2007.

  3. Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician 2004;70:1731–1738.

    Google Scholar 

  4. Blanck HM, Khan LK, Serdula MK. Use of nonprescription weight loss products: results from a multistate survey. JAMA 2001;286:930–935.

    Article  CAS  Google Scholar 

  5. Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen C, Solomon JL. An herbal supplement containing ma huang-guarana for weight loss: a randomized, double-blind trial. Int J Obes 2001;25:316–324.

    Article  CAS  Google Scholar 

  6. Greenway FL. The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent. Obes Rev 2001;2:199–211.

    Article  CAS  Google Scholar 

  7. Young R, Glennon RA. Discriminative stimulus properties of (-)ephedrine. Pharmacol Biochem Behav 1998;60:771–775.

    Article  CAS  Google Scholar 

  8. Shekelle PG, Hardy ML, Morton SC, et al. Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis. JAMA 2003;289:1537–1545.

    Article  CAS  Google Scholar 

  9. Allison DB, Fontaine KR, Heshka S, Mentore JL, Heymsfield SB. Alternative treatments for weight loss: a critical review. Crit Rev Food Sci Nutr 2001;41:1–28.

    Article  CAS  Google Scholar 

  10. Kovacs EMR, Mela DJ. Metabolically active functional food ingredients for weight control. Obes Rev 2006;7:59–78.

    Article  CAS  Google Scholar 

  11. Hutchins GM. Dietary supplements containing ephedra alkaloids. N Engl J Med 2001;344:1095–1097.

    Article  CAS  Google Scholar 

  12. Dulloo AG. Herbal stimulation of ephedrine and caffeine in the treatment of obesity. Int J Obes 2002;26:590–592.

    Article  CAS  Google Scholar 

  13. Boozer CN, Daly PA, Homel P, et al. Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes 2002;26:593–604.

    Article  CAS  Google Scholar 

  14. Kalman CM, Minsch A. Ephedrine, caffeine, and aspirin enhance fat loss under nonexercising conditions [abstract]. J Am Coll Nutr 1997;16(Suppl 2):S149.

    Google Scholar 

  15. Daly PA, Krieger DR, Dulloo AG, Young JB, Landsberg L. Ephedrine, caffeine, and aspirin: safety and efficacy for treatment of obesity. Int J Obes 1993;17(Suppl 1):S73–S78.

    Google Scholar 

  16. Vukovich, MD, Schoorman R, Heilman C, Jacob P, Benowitz NL. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate, and blood pressure. Clin Exp Pharmacol Physiol 2005;32:47–53.

    Article  Google Scholar 

  17. Fugh-Berman A, Myers A. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss: current status of clinical and basic research. Exp Biol Med 2004;229:698–704.

    CAS  Google Scholar 

  18. Bent S, Padula A, Neuhaus J. Safety and efficacy of citrus aurantium for weight loss. Am J Cardiol 2004;94:1359–1361.

    Article  Google Scholar 

  19. Penzak SR, Jann MW, Cold JA, Hon YY, Desai HD, Gurley BJ. Seville (sour) orange juice: synephrine content and cardiovascular effects in normotensive adults. J Clin Pharmacol 2001;41:1059–1063.

    Article  CAS  Google Scholar 

  20. Allison DB, Cutter G, Poehman, ET, Moore DR, Barnes S. Exactly which synephrine alkaloids does citrus aurantium (bitter orange) contain? Int J Obes 2005;29:443–446.

    Article  CAS  Google Scholar 

  21. Blumenthal M. Bitter orange peel and synephrine. Part 1. HerbalGram 2005;66. American Botanical Council. http://www.herbalgram.org/herbalgram/articleview.asp?a=2833&p=Y/. Accessed May 11, 2007.

  22. Carpene C, Galitzky J, Fontana E, Atgie C, Lafontan M, Berlan M. Selective activation of beta3-adrenoreceptors by octopamine: comparative studies in mammalian fat cells. Naunyn Schmiedebergs Arch Pharmacol 1999;359:310–321.

    Article  CAS  Google Scholar 

  23. Haller CA, Benowitz NL, Jacob P III. Hemodynamic effects of ephedra-free weight-loss supplements in humans. Am J Med 2005;118:998–1003.

    Article  Google Scholar 

  24. Colker CM, Kalman DS, Torina GC, Perlis T, Street C. Effects of Citrus aurantium, caffeine, and St. John’s wort on body fat loss, lipid levels, and mood states, in overweight healthy adults. Curr Ther Res 1999;60:145–152.

    Article  Google Scholar 

  25. Heyward VH, Stolarczyk LM. Applied Body Composition Assessment. Human Kinetics, Champaign, IL, 1996, pp 47–54.

    Google Scholar 

  26. Sale C, Harris RC, Delves S, Corbett J. Metabolic and physiological effects of ingesting extracts of bitter orange, green tea and guarana at rest and during treadmill walking in overweight males. Int J Obes 2006;30:764–773.

    Article  CAS  Google Scholar 

  27. Zenk, JL, Liekam SA, Kassen LJ, Kuskowski, MA. Effect of Lean System 7 on metabolic rate and body composition. Nutrition 2005;21:179–185.

    Article  Google Scholar 

  28. Stanko RT, Mendelow H, Shinozuka H, Adibi SA. Prevention of alcohol-induced fatty liver by natural metabolites and riboflavin. J Lab Clin Med 1978;91:228–235.

    CAS  Google Scholar 

  29. Stanko RT. Methods for preventing body fat deposition in mammals. US Patent No. 4,812,479. March 14, 1989.

    Google Scholar 

  30. Stanko RT, Adibi SA. Inhibition of lipid accumulation and enhancement of energy expenditure by the addition of pyruvate and dihydroxyacetone to a rat diet. Metabolism 1986;35:182–186.

    Article  CAS  Google Scholar 

  31. Stanko RT, Arch JE. Inhibition of regain in body weight and fat with addition of 3-carbon compounds to the diet with hyperenergetic refeeding after weight reduction. Int J Obes Relat Metab Disord 1996;20:925–930.

    CAS  Google Scholar 

  32. Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization, and nitrogen metabolism with a severely restricted diet supplemented with dihydroxyacetone and pyruvate. Am J Clin Nutr 1992;55:771–776.

    CAS  Google Scholar 

  33. Stanko RT, Reynolds HR, Hoyson R, Jonosky JE, Wolf R. Pyruvate supplementation on a low cholesterol, low fat diet: effects on plasma lipid concentrations and body composition in hyperlipidemic patients. Am J Clin Nutr 1994;59:423–427.

    CAS  Google Scholar 

  34. Stanko RT, Ferguson TL, Newman CW, Newman RK. Reduction of carcass fat in swine with dietary addition of dihydroxyacetone and pyruvate. J Anim Sci 1989;67:1272–1278.

    CAS  Google Scholar 

  35. Kalman D, Colker CM, Stark R, Minsch A, Wilets I, Antonio J. Effect of pyruvate supplementation on body composition and mood. Curr Ther Res 1998;59:793–802.

    Article  CAS  Google Scholar 

  36. Kalman D, Colker CM, Welets I, Roufs JB, Antonio J. The effects of pyruvate supplementation on body composition in overweight individuals. Nutrition 1999;15:337–340.

    Article  CAS  Google Scholar 

  37. Koh-Banerjee PK, Ferreira MP, Greenwood M, et al. Effects of calcium pyruvate supplementation during training on body composition, exercise capacity, and metabolic responses to exercise. Nutrition 2005;21:312–319.

    Article  CAS  Google Scholar 

  38. Stone MH, Sanborn K, Smith LL, et al. Effects of in-season (5 weeks) creatine and pyruvate supplementation on anaerobic performance and body composition in American football players. Int J Sports Nutr 1999;9:146–165.

    CAS  Google Scholar 

  39. Lukaski HC, Siders WA, Penland JG. Chromium picolinate supplementation in women: effects on body weight, composition, and iron status. Nutrition 2007;23:187–195.

    Article  CAS  Google Scholar 

  40. Pittler MH, Stevinson C, Ernst E. Chromium picolinate for body weight reduction: meta-analysis of randomized trials. Int J Obes 2003;27:522–529.

    Article  CAS  Google Scholar 

  41. Brown JM, McIntosh MK. Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. J Nutr 2003;133:3041–3046.

    CAS  Google Scholar 

  42. Pittler MH, Ernst E. Dietary supplements for body-weight reduction: a systematic review. Am J Clin Nutr 2004;79:529–536.

    CAS  Google Scholar 

  43. Han LK, Kimura Y, Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high fat diet. Int J Obes 1999;23:174–179.

    Article  CAS  Google Scholar 

  44. Trautwein EA, Jurgensen U, Erbersdobler HF. Choleserol-lowering and gallstone-preventing action of chitosans with different degrees of deacetylation in hamsters fed cholesterol rich-diets. Nutr Res 1997;17:1053–1065.

    Article  CAS  Google Scholar 

  45. Gades MD, Stern JS. Chitosan supplementation and fecal fat excretion in men. Obes Res 2003;11:683–688.

    Article  CAS  Google Scholar 

  46. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (HCA) as a potential anti-obesity agent. JAMA 1998;280:1596–1600.

    Article  CAS  Google Scholar 

  47. Kovacs EMR, Westerterp-Plantega MS, Saris WHM. The effects of 2-week ingestion of (-)-hydroxycitrate and (-)-hydroxycitrate combined with medium-chain triglycerides on satiety, fat oxidation, energy expenditure and body weight. Int J Obes 2001;25:1087–1094.

    Article  CAS  Google Scholar 

  48. Westerterp-Plantenga MS, Kovacs EMR. The effect of (-)-hydroxycitrate on energy intake and satiety in overweight humans. Int J Obes 2002;26:870–872.

    Article  CAS  Google Scholar 

  49. Kriketos AD, Thomson HR, Greene H, Hill JO. (-)-Hydroxycitric acid does not affect energy expenditure and substrate oxidation in adult males in a post-absorptive state. Int J Obes 1999;23:867–873.

    Article  CAS  Google Scholar 

  50. Van Loon LJC, van Rooijen JJM, Niesen B, Verhagen H, Saris WHM, Wagenmakers AJM. Effects of acute (-)-hydroxycitrate supplementation on substrate metabolism at rest and during exercise in humans. Am J Clin Nutr 2000;72:1445–1450.

    Google Scholar 

  51. Louter-van de Haar, J, Wielinga PY, Scheurink AJW, Nieuwenhuizen AG. Comparison of the effects of three different (-)-hydroxycitric acid preparations on food intake in rats. Nutr Metab 2005;2:23.

    Article  Google Scholar 

  52. Malpuech-Brugere C, Wihelmine PHG, Verboeket-vande V, Mensink RP, et al. Effects of two conjugated linoleic acid isomers on body fat mass in overweight humans. Obes Res 2004;12:591–598.

    Article  CAS  Google Scholar 

  53. Tricon S, Yaqoob P. Conjugated linoleic acid and human health: a critical evaluation of the evidence. Clin Nutr Metab Care 2006;9:105–110.

    Article  CAS  Google Scholar 

  54. Meinert Larsen T, Toubro S, Gudmundsen O, Astrup A. Conjugated linoleic acid supplementation for 1 y does not prevent weight or body fat regain. Am J Clin Nutr 2006;83:606–612.

    Google Scholar 

  55. Tricon S, Burdge GC, Kew S, et al. Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans. Am J Clin Nutr 2004;80:614–620.

    CAS  Google Scholar 

  56. Gaullier JM, Halse J, Hoye K, et al. Conjugated linoleic acid supplementation for 1 y reduces body fat mass in healthy overweight humans. Am J Clin Nutr 2004;79:1118–1125.

    CAS  Google Scholar 

  57. Riserus U, Berglund L, Vessby B. Conjugated linoleic acid (CLA) reduced abdominal adipose tissue in obese middle-aged men with signs of the metabolic syndrome: a randomized controlled trial. Int J Obes 2001;25:1129–1135.

    Article  CAS  Google Scholar 

  58. Metz JA, Karanja N, Torok J, McCaron DA. Modification of total body fat in spontaneously hypertensive rats and Wistar-Kyoto rats by dietary calcium and sodium. Am J Hypertens 1988;1:58–60.

    CAS  Google Scholar 

  59. Bursey RG, Sharkey T, Miller GD. High calcium intake lowers weight in lean and fatty Zucker rats [abstract]. FASEB J 1989;3137:A265.

    Google Scholar 

  60. Teegarden D, Lin YC, Weaver CM, Lyle RM, McCabe GP. Calcium intake related to change in body weight in young women [abstract]. FASEB J 1999;13:A873.

    Google Scholar 

  61. Zemel MB, Shi H, Zemel PC, DiRienzo D. Calcium and calcium-rich dairy products reduce body fat [abstract]. FASEB J 1999;12:LB211.

    Google Scholar 

  62. Zemel MB, Shi H, Greer B, DiRienzo D, Zemel P. Regulation of adiposity by dietary calcium. FASEB J 2000;14:1132–1138.

    CAS  Google Scholar 

  63. Davies KM, Heaney RP, Recker RR, et al. Calcium intake and body weight. J Clin Enocrinol Metab 2000;85:4635–4638.

    Article  CAS  Google Scholar 

  64. Shapses, SA, Stanley H, Heymsfield SB. Effect of calcium supplementation on weight and fat loss in women. J Clin Endocrinol Metab 2004;89:632–637.

    Article  CAS  Google Scholar 

  65. Barr SI, McCarron DA, Heaney RP, et al. Effects of increased consumption of fluid milk on energy and nutrient intake, body weight, and cardiovascular risk factors in healthy older adults. J Am Diet Assoc 2000;100:810–817.

    Article  CAS  Google Scholar 

  66. DeJongh ED, Binkley TL, Specker BL. Fat mass gain is lower in calcium-supplemented than in unsupplemented preschool children with low dietary calcium intakes. Am J Clin Nutr 2006;84:1123–1127.

    CAS  Google Scholar 

  67. Gunther CW, Legowski AP, Lyle RM, et al. Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. Am J Clin Nutr 2005;81:751–756.

    CAS  Google Scholar 

  68. Haub MD, Simons TR, Cook CM, Remig VM, Al-Tamimi EK, Holcomb CA. Calcium-fortified beverage supplementation on body composition in postmenopausal women. Nutr J 2005;4:21.

    Article  Google Scholar 

  69. Zemel MB, Thompson W, Milstead A, Morris K, Campbell P. Calcium and dietary acceleration of weight and fat loss during energy restriction in obese adults. Obes Res 2004;12:582–590.

    Article  CAS  Google Scholar 

  70. Zemel MB, Shi H, Zemel PC. Materials and methods for the treatment or prevention of obesity. US patent no. 6,384,087; May 7, 2002.

    Google Scholar 

  71. Walsh DE, Yaghoubian V, Behforooz A. Effect of glucomannan on obese patients: a clinical study. Int J Obes 1984;8:289–293.

    CAS  Google Scholar 

  72. Keithly J, Swanson B. Glucomannan and obesity: a critical review. Altern Ther Health Med 2005;11:30–34.

    Google Scholar 

  73. Pittler MH, Ernst E. Guar gum for body weight reduction: meta-analysis of randomized trials. Am J Med 2001;110:724–730.

    Article  CAS  Google Scholar 

  74. Birketvedt GS, Shimshi M, Erling T, Florholmen J. Experiences with three different fiber supplements in weight reduction. Med Sci Monit 2005;11:PI5–P18.

    Google Scholar 

  75. Pittler MH, Schmidt K, Ernst E. Adverse events of herbal food supplements for body weight reduction: a systematic review. Obes Rev 2005;6:93–111.

    Article  CAS  Google Scholar 

  76. Cowburn G, Hillsdon, M, Hankey CR. Obesity management by life-style strategies. Br Med Bull 1997;53:389–408.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Eckerson, J.M. (2008). Weight Loss Nutritional Supplements. In: Nutritional Supplements in Sports and Exercise. Humana Press. https://doi.org/10.1007/978-1-59745-231-1_8

Download citation

Publish with us

Policies and ethics